Our data revealed that most DNA methylation changes in monocytes derived from severe COVID-19 patients occurred in genomic sites enriched in PU.1 binding motifs, consistent with earlier studies showing its role as a pioneer TF directly recruiting TET2 and DNMT3b [77]. The gene discussed is DNMT3B; the disease is COVID-19.